Our Current Initiatives | MNeuronet | Michigan Medicine

COVID-19

Opening a multidisciplinary diabetes clinic to care for COVID-19 patients and monitor their long-term recovery
Understanding why diabetes patients are at a greater risk of COVID-19 complications
Creating a protocol to identify which diabetes patients are at highest risk
Developing new treatments for diabetic patients suffering from high blood sugar surges caused by COVID-19
Identifying long-term and permanent damage to brain, heart, and kidney in COVID-19 survivors

Conducting a clinical study to determine if surgical weight loss and/or exercise can prevent nerve damage and improve thinking
Studying why children and teenagers with obesity, prediabetes, and diabetes develop nerve damage
Identifying risk factors for brain and nerve damage in patients with type 1 and type 2 diabetes
NETWORK AFFILIATES: Dr. Troels Jensen (Aarhus University, Denmark), Dr. Robert Nelson (National Institutes of Health), Dr. Amanda Peltier (Vanderbilt University)

Designing and launching the “ﬁrst in human” clinical trial using stem cells to treat Alzheimer’s disease
Determining how diabetes and obesity can lead to Alzheimer’s disease
Exploring what diets promote a healthy brain
Investigating how a healthy immune system contributes to a healthy brain
Identifying environmental pollution exposures that may contribute to Alzheimer’s disease
NETWORK AFFILIATES: Dr. David Bennett (Oxford Unversity, England), Dr. Catrina Robinson (Medical University of South Carolina), Dr. Velandai Srikanth (Monash University, Australia), Dr. Vijay Viswanathan (Chennai, India)

Facilitating patient participation in three national drug trials at the Pranger ALS Clinic
Designing a clinical trial to test if immunosuppressant drugs can slow
ALS progression
Understanding why Michigan has the highest ALS prevalence in the U.S.A. by examining the interaction of genetics and chemical exposures in ALS patients
Advocating for a cleaner environment by raising awareness of how pollution (e.g., legacy pesticides, fIame retardants, air pollution) contributes to ALS
NETWORK AFFILIATES: Dr. Tamir Ben-Hur and Dr. Benjamin Reubinoff (Hadassah-Hebrew University, Israel), Dr. Junguk Hur (University of North Dakota), Dr. Daniel Newman (Henry Ford Hospital)